News Hub | News Direct

All Industries


Article thumbnail News Release

MicroStrategy: A Potential Bitcoin Proxy? Now You Can Trade Its Moves With Leveraged MSTR ETFs

Benzinga

By Meg Flippin, Benzinga Looking for Bitcoin exposure with a boost? Click here to learn about the T-Rex 2X Long and Short MSTR Daily Target ETF. When it comes to cryptocurrency exposure, indirect can sometimes be best. Sure, you can buy Bitcoin and try to time the market to make a simple profit. Or, if you’re a savvy trader, you may want to consider a leveraged bet. After all, Bitcoin is volatile, enabling investors to make money on both the upside and the downside. REX Shares has released two funds that offer the opportunity to do exactly that. REX Shares recently filed with the Securities and Exchange Commission for a new 2x-leveraged MicroStrategy ETF, the T-Rex 2X Long MSTR Daily Target ETF, which will track the daily performance of MicroStrategy Inc. (NASDAQ: MSTR) multiplied by 200%. There is also the T Rex 2X Inverse MSTR Daily Target ETF which seeks daily investment results, before fees and expenses, of 200% of the inverse (or opposite) of the daily performance of MSTR. With these two ETFs, bears and bulls can get in on the Bitcoin ride both up and down. It’s worth noting that the fund isn’t suitable for all investors; it’s designed to be used only by knowledgeable investors who are able to understand the possible consequences of seeking daily inverse (-2.0X) investment results and the risks associated with the use of shorting, and who are willing to monitor their portfolios frequently. The fund isn’t intended for, nor appropriate for, investors who won’t be actively monitoring and managing their portfolios. For periods longer than a single day, the fund will lose money if the Reference Assets’ performance is flat, and it is possible that the fund will lose money even if the Reference Assets’ performance decreases over a period longer than a single day. An investor could lose the full principal value of their investment within a single day if the price of the Reference Assets goes up by more than 50% in one trading day. The fund only intends to use reference assets that are traded on a U.S. regulated exchange. MicroStrategy’s Large Bitcoin Exposure So why MicroStrategy? The software company happens to be an early and big holder of Bitcoin. It currently owns 226,500 BTC – valued at nearly $13 billion – and is in the market for more. Earlier this month, MicroStrategy announced a plan to issue $700 million in notes due in 2028 to purchase additional Bitcoin. Given its heavy exposure to Bitcoin, MicroStrategy is known for its volatility, which many leveraged traders see as a positive. As of September, MicroStrategy’s 30-day implied future volatility was at a mean of 0.8466. The volatility can be so high with MicroStrategy that Bloomberg ETF analyst Eric Balchunas said on X that the new funds will be the most volatile ETFs ever in the United States, calling it the "ghost pepper of ETF hot sauce." Seek to boost your Bitcoin returns with leveraged ETFs from REX Shares. REX Shares says that investing in a MicroStrategy leveraged ETF can offer a distinct way to gain amplified exposure to both MicroStrategy’s core business and its Bitcoin holdings. Compared to a regular Bitcoin ETF, a leveraged ETF provides magnified daily returns (2x or -2x) on MicroStrategy's stock, which often correlates with Bitcoin’s price. This, the company argues, can make it appealing to investors looking for short-term, high-risk/high-reward opportunities that mirror Bitcoin’s movements but also incorporate the performance of MicroStrategy’s software business, adding another layer of potential upside or downside. Understanding Leveraged ETFs Leveraged ETFs are funds that use debt or derivatives to increase the returns of a stock, bond, index or currency. They can generate returns quickly, often more than the tracked index or assets, and can also provide a way for investors to hedge against a stock going up or down. A traditional ETF seeks to match the index it is tracking on a one-to-one ratio by holding the stock in its fund. A leveraged ETF aims to amp up those returns to a two-to-one or three-to-one ratio by using debt or financial derivatives including option contracts to boost the returns on a daily basis. Rex Shares says it believes Bitcoin is perfect for this, given its volatility. Whether bullish or bearish on Bitcoin, these ETFs may help traders easily engage with the asset’s growth patterns. However, while the leverage can translate to amplified gains, it can also similarly lead to magnified losses. These ETFs are best suited for those who can actively manage the inherent risks of leverage and are looking to capitalize on short-term trends, and daily leveraged ETFs should not be held for a period longer than one day. So far in 2024, Bitcoin has been volatile, enjoying huge runups and declines. Despite it all, Bitcoin was up 35% year to date as of Sep. 10 and 464% higher over a five-year period. Supply and demand, investor sentiment, government actions and regulations, fraud and media hype closely influence Bitcoin’s performance. All that creates volatility which presents an opportunity for sophisticated investors to make money. That hasn’t been lost on MicroStrategy investors. The stock sports a market cap of about $24 billion and is up over 750% over the past five years. The Best Of Both Worlds With T-Rex’s latest ETF, investors can get exposure either way – whether they think Bitcoin prices will decline or rise. They’re not the only ETFs that give T-Rex customers Bitcoin exposure. In July, REX Shares, in collaboration with Tuttle Capital Management launched the T-REX 2X Long Bitcoin Daily Target ETF (BATS: BTCL) and the T-REX 2X Inverse Bitcoin Daily Target ETF (BATS: BTCZ), providing 200% and -200% exposure to Bitcoin’s daily performance. “Bitcoin’s meteoric rise in 2024 has captured the attention of investors and traders worldwide,” Scott Acheychek, COO of REX Financial, REX Shares parent company, said at the time. "By launching 2X leveraged and inverse Bitcoin ETFs, we’re arming traders with powerful tools to capitalize on Bitcoin’s price swings like never before." Investor appetite for cryptocurrency-focused investment products has been growing since Bitcoin exchange-traded products designed to track the performance of Bitcoin debuted in January. Since then, spot Bitcoin ETFs have amassed $61 billion in assets under management. REX Shares plans to capitalize on the trend with its Bitcoin-focused leveraged ETFs. To learn more about the T-Rex MicroStrategy and Bitcoin ETFs, click here. Featured photo by Joshua Mayo on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Investing in the Funds is not equivalent to investing directly in the ‘Reference Assets’. The Fund will not invest directly in Bitcoin or directly short Bitcoin. Investment Risks: Investing in the Funds involves a high degree of risk. As with any investment, there is a risk that you could lose all or a portion of your investment in the Funds. An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about REX Shares. To obtain a Fund’s prospectus and summary prospectus call 844-802-4004. A Fund’s prospectus and summary prospectus should be read carefully before investing. The Fund may enter into swap agreements with a limited number of counterparties. If the underlying security has a dramatic move in price that causes a material decline in the Fund’s NAV over certain stated periods agreed to by the Fund and the counterparty, the terms of a swap agreement between a Fund and its counterparty may permit the counterparty to immediately close out all swap transactions with the Fund. There is a risk that no suitable counterparties will be willing to enter into, or continue to enter into, transactions with the Fund and, as a result, the Fund may not be able to achieve its leveraged investment objective or may decide to change its leveraged investment objective.Investing in a REX Shares ETF may be more volatile than investing in broadly diversified funds. The use of leverage by a Fund increases the risk to the Fund. The REX Shares ETFs are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk, consequences of seeking daily leveraged, or daily inverse leveraged, investment results and intend to actively monitor and manage their investment. For the complete disclosure statement, click HERE. The Fund has a daily investment objective and the Fund’s performance for periods greater than a trading day will be the result of each day’s returns compounded over the period, which is very likely to differ from -200% of the Reference Assets’ performance, before fees and expenses. Compounding affects all investments but has a more significant impact on funds that are inverse and that rebalance daily and becomes more pronounced as volatility and holding periods increase. Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs), interest rates or indexes. Investing in derivatives may be considered aggressive and may expose the Fund to greater risks, and may result in larger losses or small gains, than investing directly in the reference assets underlying those derivatives, which may prevent the Fund from achieving its investment objective. Daily Correlation Risk. There is no guarantee that the Fund will achieve a high degree of correlation to MSTR and therefore achieve its daily leveraged investment objective. Industry Concentration Risk. The Fund will be concentrated in the industry to which MicroStrategy Inc. is assigned (i.e., hold more than 25% of its total assets in investments that provide inverse exposure to the industry to which MicroStrategy Inc. is assigned). Bitcoin Risk. While the Fund will not directly invest in digital assets, it will be subject to the risks associated with Bitcoin by virtue of its investments in options contracts that reference MSTR. Fixed Income Securities Risk. When the Fund invests in fixed income securities, the value of your investment in the Fund will fluctuate with changes in interest rates. Liquidity Risk. Holdings of the Fund may be difficult to buy or sell or may be illiquid, particularly during times of market turmoil. Non-Diversification Risk. The Fund is classified as “non-diversified” under the Investment Company Act of 1940, as amended. New Fund Risk. As of the date of this prospectus, the Fund has no operating history and currently has fewer assets than larger funds. Distributor: Foreside Fund Services, LLC, member FINRA, not affiliated with REX Shares or the Funds’ investment advisor Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 25, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

Texicare Partners with TempoPay to Make Paying For Health Care Simpler and More Accessible for Small Business Groups in Texas

TempoPay

TempoPay, a flexible payment solution that helps bridge the affordability gap in health care, and Texicare, the health affiliate of Texas Mutual, today announced that employees of small business groups selecting Texicare health plans can now access TempoPay to help manage everyday healthcare expenses. TempoPay, a subsidiary of HPS/PayMedix, is a flexible payments platform that provides employees with the ability to pay their health care bills over time without interest, fees or credit checks. The TempoPay Visa® card can be used to pay for everything from medical care and prescriptions to vision and dental bills and other health and wellness-related costs not covered by employees’ plans. Texicare members can sign up to access $1,500 in interest-free financing through TempoPay any time and have the flexibility to choose repayment terms. By building this unique financial tool into the health plan, members can manage their out-of-pocket expenses in a way that works for them, keeping health care and well-being within the household budget. “For many Texans, out-of-pocket expenses are a barrier to getting needed care,” said Meredith Duncan, CEO of Texicare. “That’s why we’re partnering with TempoPay—to make health care more accessible for all our members so they can focus first and foremost on their well-being and manage their out-of-pocket costs in a way that works for them. Together, we are aligned in our mission to build a healthier, happier Texas.” Texicare aims to change the health care ecosystem by providing small businesses with innovative solutions that increase access to high-quality care. Texicare’s health plans are designed with the employee experience in mind—they are easy to use and focused on the holistic well-being of employees and their families. The addition of TempoPay will enhance these offerings and open access to small businesses across Texas, allowing employees to access health care when they need it. “TempoPay is a perfect fit for Texas employers who can now offer their employees a flexible way to pay for their health care expenses, and we are proud to be partnering with Texicare,” Erika Davison-Aviles, Co-founder of TempoPay said. “Through this partnership, we accelerate our mission to help hardworking people and their families get care when they need it and make health care accessible for all." About TempoPay TempoPay partners with employers to help their employees manage their medical costs with interest-free financing and flexible repayment options. With the TempoPay Visa ® card employees can take control of how they pay for healthcare without added stress, providing simple access to the financial security needed for happier, healthier lives. About Texicare Texicare, the health affiliate of Texas Mutual, is changing the health care ecosystem by providing small businesses with innovative solutions that increase access to easy-to-use, more affordable, quality health care for employees and Texas families. Texicare’s vision is to transform the health care ecosystem for the better, helping to create a healthier and happier Texas. To learn more about Texicare, visit www.texicare.com. Media Contacts: For Texicare, Emma Chase Red Fan Communications press@texicare.com 512-917-4319 For TempoPay Kaitlynn Cooney Brodeur Partners kcooney@brodeur.com 609-351-5944 Contact Details Brodeur Partners Kaitlynn Cooney +1 609-351-5944 kcooney@brodeur.com Company Website https://www.tempopay.com

September 25, 2024 08:00 AM Eastern Daylight Time

Article thumbnail News Release

drive21, Van Wagner Collaborate to Elevate In-Venue Branding and Fan Engagement Across College Athletics

drive21

drive21, a leader in experiential design and marketing solutions, today announced a strategic relationship with leading collegiate athletics marketing agency, Van Wagner to become a preferred experiential graphic design and implementation provider for Van Wagner. Van Wagner is recognized for its expertise in collegiate sponsorship sales and multi-media rights and will collaborate with drive21 to redefine branding strategies, drive revenue growth, and create Name, Image and Likeness (NIL) execution opportunities in the collegiate sports industry. Through this relationship, Van Wagner’s collegiate clients will be afforded advantageous pricing and access to drive21’s suite of services to provide innovative branding and design solutions across their venues; driving innovative solutions that bridge the gap between brand aspirations and reality, creating immersive environments that resonate with audiences and drive tangible business results. "This relationship represents a significant step forward in our mission to transform sports and entertainment venues into impactful environments that are also powerful marketing tools," said Warren Godridge, drive21 Founder and President. "By collaborating with Van Wagner, we can leverage our creativity and expertise to deliver a consistent brand experience across all venues, enhancing the value for brands, universities, and fans alike." “Traditional approaches often focus solely on aesthetics and overlook the potential to maximize partnership, sponsorship and NIL opportunities, leaving untapped value on the table” said John Libro, Head of Sports and Entertainment at drive21. “Working with Van Wagner College will allow us to push the boundaries of experiential design and transform collegiate athletic facilities into dynamic revenue-generating tools that engage fans and drive real business growth.” This relationship may also offer an even more comprehensive solution to collegiate clients by providing new NIL revenue streams. Through this collaboration with drive21, a portion of the facility’s expenditure can be reallocated to the universities’ NIL efforts. This allows universities to offer a more engaging experience for athletes and fans while creating dynamic environments supporting athletic performance, fan engagement and brand partnerships. "drive21’s ability to seamlessly integrate brand experiences into our facilities is a game-changer for our clients,” said Mark Donley, Chief Revenue Officer at Van Wagner College. “Through our arrangement with drive21, our university clients have an opportunity to access the expertise of drive21 to not only enhance their facilities but also ensure a consistent and high-quality experience for a variety of initiatives at an advantageous rate. It's truly a win-win-win scenario." The first major joint effort was a collaboration at Florida International University for the brand implementation of the newly named Pitbull Stadium. drive21 and Van Wagner played a key role in creating cohesive branding for the first college athletic venue named after a musician, exampling the transformative potential of experiential design and strategic branding. To learn more about the partnership, or drive21’s sports, entertainment and hospitality solutions, please visit www.drive21.com. About drive21 drive21 elevates the sports, entertainment, and hospitality industries by delivering one-of-a-kind branded venue experiences. A leader in experiential design and marketing solutions, drive21 bridges the gap between imagination and reality to deliver functional and impactful environments through design, fabrication, implementation, and holistic project management. Servicing organizations including MLB, MLS and NCAA institutions, drive21 helps its clients maximize partnership and sponsorship revenue and turns ordinary environments into extraordinary works of art. For more information, visit www.drive21.com. About Van Wagner Van Wagner is a leading sports advertising and entertainment agency with global expertise in filmed and live entertainment, sponsorship sales, multi-media rights, and aerial advertising. Van Wagner creates, advises, and sells for world-class teams, leagues, brands, and properties. An innovator in the sports and media business, Van Wagner is a global leader in high-impact broadcast visible signage throughout the MLB, NBA, NCAA, and international soccer, sponsorships sales, college multi-media rights, and in-venue content production at the world’s biggest sporting events. For more information, visit www.vanwagner.com. Contact Details Hot Paper Lantern Jackson Gaskins jgaskins@hotpaperlantern.com Company Website https://drive21.com

September 25, 2024 08:00 AM Eastern Daylight Time

Article thumbnail News Release

BestGrowthStocks.Com Issues a Comprehensive Analysis of Kaival Brands Merger with Global Logistics Provider Delta Corporation

Kaival Brands Innovations Group Inc (KAVL)

NEW YORK, NY / NewsDirect / September 25th, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued an in-depth analysis of Kaival Brands Merger with Global Logistics Provider Delta Corp. Holdings Limited. Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) has garnered significant investor attention following this transformational merger announcement with Delta. Best Growth Stock's full report offers an in-depth analysis of Delta and Kaival's operations, competitive advantages, potential catalysts, growth drivers, financials, and more. Access this full analysis free here: https://bestgrowthstocks.com/access-kaival-delta-merger-analysis/ About Kaival Brands Based in Grant-Valkaria, Florida, Kaival Brands is a company focused on incubating and commercializing innovative products into mature and dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (ENDS) also known as “e-cigarettes” for use by customers 21 years and older. Our business plan is to seek to diversify into distributing other nicotine and non-nicotine delivery system products (including those related to hemp-derived cannabidiol (known as CBD) products). Kaival Brands and Philip Morris Products S.A. (via sublicense from Kaival Brands) are the exclusive global distributors of all products manufactured by Bidi Vapor LLC. Based in Melbourne, Florida, Bidi Vapor maintains a commitment to responsible, adult-focused marketing, supporting age-verification standards and sustainability through its BIDI® Cares recycling program. Bidi Vapor's premier device, the BIDI® Stick, which is distributed exclusively by Kaival Brands, is a premium product made with high-quality components, a UL-certified battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. Learn more about Kaival Brands at https://ir.kaivalbrands.com/overview/default.aspx. About Delta Delta Corp Holdings Limited is a fully integrated global enterprise engaged in logistics, fuel supply, and asset management services, primarily supporting the international supply chains of commodity, energy, and capital goods producers. With its headquarters in London, Delta operates through three main segments: Bulk Logistics, Energy Logistics, and Asset Management. The company also maintains executive offices in Dubai and New York, and boasts a significant commercial presence in Singapore, Rotterdam, New Delhi, and Mumbai. For more information, please see Delta’s website at www.wearedelta.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.Com SOURCE: BestGrowthStocks.Com Contact Details Media Source LLC Steve Macalbry +1 989-274-7778 editor@bestgrowthstocks.com Company Website https://bestgrowthstocks.com/

September 25, 2024 07:00 AM Eastern Daylight Time

Article thumbnail News Release

Vanguard Green Investment Limited announces its transformation from the healthcare industry to the ESG service industry.

Vanguard Green Investment Limited

Mu Global Holding Limited (OTCPINK:MUGH) announced that the company is changing it’s name to Vanguard Green Investment Limited. Effective 25 Jun, 2024 subject to satisfying applicable legal requirements. This more closely aligns the Company's legal name with it's brand name in marketplace. The company's shares of common stock will continue to be listed on the OTCMarkets Exchange under OTCPINK ticker symbol "MUGH". No action is needed from current Mu Global Holding Limited stockholders. Vanguard Green Investment Limited, formerly a leading company in the healthcare industry, is proud to announce its transformation to a ESG Advisor Service Company under the leadership of Chairman Niu Yenyen. This move marks a significant step towards building a sustainable future for earth and promoting female leadership in the business world. Chairman Niu Yenyen, a visionary leader with strong commitment to environmental sustainability, spearheaded the transformation to VANGUARD GREEN INVESTMENT LIMITED. With her extensive knowledge andexpertise in the healthcare industry, she recognized the urgency for businesses to shift towards green energy solutions to combat global climate and environmental issues. Under her leadership, the company successfully transitioned from its original focus on healthcare to ESG Advisor Service in renewable energy projects. This transformation not only aligns VANGUARD GREEN INVESTMENT LIMITED’s global efforts to reduce carbon emissions, it also opens up new opportunities for the company. By focusingon ESG Advisor Service in green energy, the company is not only contributing to a greener and healthier planet, but is also generating sustainable returns for its shareholders. This move also highlights the company's commitment to promoting female leadership in the business world and breaking gender stereotypes. Chairman Niu Yenyen believes that the transformation is just the beginning of VANGUARD GREEN INVESTMENT LIMITED's journey towards a more sustainable future. She envisions the company becoming a ESG Advisor leader in the green energy sector and inspiring other businesses to follow suit. With her strong determination and the company's dedication to green investments, VANGUARD GREEN INVESTMENT LIMITED is on its way to making a positive impact on the environment and society. As the world faces pressing challenges of global climate and environmental issues, VANGUARD GREEN INVESTMENT LIMITED's transformation serves as a shining example of how businesses can play a significant and decisive role in creating a sustainable future. The company's commitment to green energy and female leadership is a testament to its vision of building a better world for future generations. Interview video links: https://youtu.be/MwuWYdau1to Contact Details Vanguard Green Investment Limited Niu YenYen +1 319-304-1192 info@v-gil.com Carat W Holding Ptd., Ltd Shing Ya Wang +886 987 314 013 info@cw-h.net

September 24, 2024 08:09 PM Eastern Daylight Time

Image
Article thumbnail News Release

UNOS applauds House action to prohibit discrimination in organ transplants

United Network for Organ Sharing

Today, Maureen McBride, Ph.D., the CEO of the United Network for Organ Sharing (UNOS), issued the following statement after the U.S. House of Representatives passed the Charlotte Woodward Organ Transplant Discrimination Prevention Act. This legislation prohibits discrimination in organ transplantation against individuals with physical or intellectual disabilities. “The U.S. organ transplant matching system was created 40 years ago to serve every patient in need, which is why we strongly believe no one should be denied placement on the national waitlist solely because of his or her disability. We’re pleased to see the House pass this legislation, which advances our shared goal of ensuring equity for patients with disabilities in our nation’s donation and transplant system. Thank you, U.S. Reps. Kat Cammack and Debbie Dingell for your leadership. We look forward to continuing to work with you to ensure all Americans, regardless of their disability, have equitable access to organ transplants, and urge the U.S. Senate to quickly pass this legislation led by U.S. Sens. Marco Rubio and Maggie Hassan.” About UNOS United Network for Organ Sharing (UNOS) is the mission-driven non-profit serving as the nation’s transplant system under contract with the federal government. We lead the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to honoring the gifts of life entrusted to us and to making lifesaving transplants possible for patients in need. Working together, we leverage data and advances in science and technology to continuously strengthen the system, increase the number of organs recovered and the number of transplants performed, and ensure patients across the nation have equitable access to transplant. Contact Details United Network for Organ Sharing Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

September 24, 2024 05:25 PM Eastern Daylight Time

Image
Article thumbnail News Release

U.S. Treasury Department's CDFI Fund Announces Fiscal Year 2023 NMTC Awards

New Markets Tax Credit Coalition

The U.S. Department of the Treasury's CDFI Fund announced the Calendar Year 2023 New Markets Tax Credit (NMTC) allocation awards last week. The CDFI Fund awarded $5 billion to 104 Community Development Entities (CDEs) headquartered in 35 states, Puerto Rico and the District of Columbia. "For more than two decades, the federal New Markets Tax Credit has been a unique and flexible community development tool, successfully attracting investment capital and boosting economic activity in low-income areas," said Bob Rapoza, spokesman for the NMTC Coalition. "In fact, the NMTC has leveraged an unprecedented level of investment to low-income communities—generating more than $135 billion in total capital investment through public-private partnerships that created more than 1.2 million jobs." The CDFI Fund estimates that the $1.2 billion in NMTC allocations (more than 20 percent) will be deployed to rural America, and at least 85 percent of the $5 billion total will go to severely distressed communities. The CDFI Fund indicated 196 CDEs applied for allocations for a total demand of $14.7 billion in tax credits. However, with 104 successful applications (53 percent) receiving $5 billion, the availability of credits continues to meet only a fraction of the true demand in communities across America. Established in 2000 in the Community Renewal Tax Relief Act (P.L.106-554), the New Markets Tax Credit is a bipartisan effort to stimulate investment and economic growth in low-income urban neighborhoods and rural communities. The NMTC provides a shallow federal tax credit of 39 percent, taken over seven years, for investments in census tracts where the individual poverty rate is at least 20 percent or where the median family income does not exceed 80 percent of the area median. Since its inception, the NMTC program has financed more than 8,500 projects, including nearly 3,000 community services and facilities, such as hospitals, schools, daycare centers, and non-profit service providers – all in areas that lacked access to quality facilities before the NMTC investments. At the end of 2020, Congress extended the Credit through 2025 at $5 billion in annual credit authority, the largest ever NMTC extension. Without congressional intervention, the program may expire, once again, in 2025. “During this Congress, leaders in both the U.S. Senate and House introduced the New Markets Tax Credit Extension Act, H.R. 2539 and S. 234, bipartisan legislation to make the NMTC a permanent part of the Internal Revenue Code,” added Rapoza. “Establishing permanence will provide certainty in delivering resources to low-income and marginalized communities, creating jobs, increasing economic opportunity and improving lives at a time when underserved communities face significant challenges. It’s time for the NMTC program, with its proven track record and its bipartisan, bicameral support, to become permanent.” For examples of how the NMTC is making an impact in each state, see the NMTC Coalition's Project Profile Database. The Coalition also released the 20th anniversary edition of its NMTC Progress Report on June 5 th, which documents the NMTC impact in Calendar Year 2023. The New Markets Tax Credit (NMTC) was enacted in 2000 to stimulate private investment and economic growth in low-income urban neighborhoods and rural communities that lack access to the patient capital needed to support and grow businesses, create jobs, and sustain healthy local economies. Since its inception, the NMTC has generated more than one million jobs. Today, due to the NMTC, more than $135 billion is hard at work in underserved communities in all 50 states, the District of Columbia, and Puerto Rico. For more information, visit www.NMTCCoalition.org. Contact Details Greg Wilson +1 571-239-7474 gregwilsonpr@gmail.com Company Website https://nmtccoalition.org/

September 24, 2024 02:19 PM Eastern Daylight Time

Article thumbnail News Release

Technology Select Sector SPDR Fund (XLK) an Interesting Option for Technology Investors

Select Sector SPDR

The Technology Select Sector SPDR Fund (XLK) continues to be a cornerstone in the realm of technology investing, providing comprehensive coverage of the U.S. technology sector. This fund offers focused exposure for both individuals and institutions. Starting with components of the S&P 500 within the technology industry, XLK offers an efficient way to gain exposure to this dynamic sector. This ETF is carefully structured, featuring a roster of technology giants that have shown resilience. The fund's composition reflects substantial holdings in some of the most influential and innovative companies in the United States. Key Holdings* of the Technology Select Sector SPDR Fund (XLK) include: Apple (14.94%) Microsoft (13.94%) Nvidia (12.29%) Broadcom (4.52%) Oracle (3.02%) Salesforce (2.90%) Advanced Micro Devices (2.83%) Adobe (2.60%) Accenture (2.37%) Cisco (2.35%) These key holdings illustrate XLK ETF's significant market position, which mirrors the ongoing relevance and innovation within the technology sector. The fund manages total assets exceeding $69 billion, with an expense ratio of 0.09%**. This balanced portfolio approach allows investors to participate in the potential of the technology sector, leveraging the strength and stability of well-established companies. The XLK ETF continues to serve as a vital tool for those aiming to stay aligned with the technological advancements and economic impacts driven by these leading corporations. Moreover, the XLK fund has been a consistent choice for investors wanting to take part in the innovative edge of the tech industry. By maintaining substantial investments in high value tech companies, XLK is an excellent vehicle for its stakeholders to benefit from advancements in the sector. Investors seeking diversified exposure to the tech sector may find XLK's portfolio appealing. The Technology Select Sector SPDR Fund offers an opportunity to engage with a portfolio comprising these tech giants while ensuring diversification across various technology industries. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. *Holdings, Weightings & Assets as of 9/23/24 subject to change **Ordinary brokerage fees apply DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and nondiversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007815 EXP 11/30/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

September 24, 2024 01:00 PM Eastern Daylight Time

Article thumbnail News Release

Taglich Brothers Maintains Speculative Buy Rating On Cosmos Health With $4 Price Target, Highlighting Potential Valuation Upside

Marel Corporation Ltd

By Marel Corp Cosmos Health ($COSM or 'Cosmos') is a global healthcare group that remains significantly undervalued by the market, despite strong execution and broad diversification across multiple sectors. The company boasts an innovative R&D division that leverages AI-driven drug repurposing, along with ownership of proprietary pharmaceutical and nutraceutical brands like Sky Premium Life. As a vertically integrated manufacturer of medicines, Cosmos is strategically positioned within the healthcare industry. Additionally, its logistics arm, CosmoFarm, distributes healthcare products to over 1,000 pharmacies, while its telehealth platform further strengthens the company’s presence in the evolving healthcare landscape. Despite the company generating nearly $60 million in annual revenue—expected to grow to $155.80 million by 2027, according to the company’s guidance for the 2024-2027 period—its market cap remains depressed at just around $20 million. The share price has dropped significantly over the past couple of years, despite notable progress on multiple fronts. Based on the guidance provided issued by the company, it expects to be highly profitable in the coming years, with EBITDA projected to reach nearly $30 million by 2027. Specifically, the company issued the following guidance: The anticipated achievements are expected to result from a combination of strategic initiatives, including a focus on higher-margin business segments, operational synergies, and enhanced cost efficiency. As highlighted by the company, the following key priorities could drive this growth: Expansion of Sky Premium Life's global footprint and product range, introducing new formulas, therapeutic areas, and customized offerings. This will be supported by strategic partnerships with exclusive distributors and digital channels. Global launch of C-Sept and C-Scrub, both of which possess significant market potential and face limited competition. Production is being scaled up, with additional products in the development pipeline. Expansion of generic pharmaceuticals across the EU and international markets, with a focus on advanced generics and innovative OTC products. Optimization of Contract Manufacturing Organization (CMO) operations, prioritizing high-demand medicines and competitive pricing strategies. Progress toward World Medical Organization (WMO) patent approval and completion of clinical trials for the CCX obesity pill by 2025, with commercialization anticipated in 2026. Driving organic growth by integrating the pharmacy distribution network to enhance efficiency and scalability. Corporate reorganization efforts, focusing on cost-cutting initiatives and optimizing asset and resource utilization through the integration of business units. These initiatives aim to propel the company forward while delivering sustained profitability and operational growth. Sharing the company’s optimistic outlook, Taglich Brothers recently published an updated research report on the company's common stock. Taglich maintains a Speculative Buy rating with a $4 price target, implying a nearly four-fold increase in the share price over the next 12 months. Taglich estimates that the company’s valuation should improve alongside revenue growth, which is expected to translate into operating profits and positive cash flow. Currently, Cosmos's price-to-sales multiple (0.3x) significantly trails the sector average of 2.4x for comparable companies in medical distribution and drug manufacturing, indicating a potential catch-up opportunity. Moving forward, investors are likely to assign a valuation multiple closer to industry norms. Even with a conservative approach, applying a lower-than-average price-to-sales multiple of 1.4x to the 2025 sales per share forecast of $3.86 supports the $4 price target, accounting for execution risks and potential warrant dilution. Recently, the company has rapidly secured distribution agreements for its proprietary Sky Premium Life brand across the GCC—including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates—as well as in European markets like Slovakia, Hungary, Poland, and Czechia. It has even signed exclusivity agreements to distribute real-time mpox (formerly monkeypox) PCR tests as far as India. In summary, Cosmos Health is a company worth monitoring as it works to position itself for potential alignment with industry peers. Featured image sourced from Shutterstock Marel Corp is an investor in stocks, employing diverse strategies across sectors and company sizes. This post was authored by an external contributor and does not represent Benzinga's opinions and has not been edited for content. This contains sponsored content and is for informational purposes only and not intended to be investing advice. Contact Details BDG Communications +44 20 7097 1653 info@bdgcommunications.com

September 24, 2024 12:00 PM Eastern Daylight Time

Image
1 ... 4142434445 ... 3764